ViraEpi4067 | Epstein barr virus (EBV) | Zp | NA | 103735 | 103735 | No methylation | 0% | PTLD10 tumor samples | PTLD tumor sample | 4 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | ViraEpi4068 | Epstein barr virus (EBV) | Zp | NA | 103746 | 103746 | No methylation | 0% | PTLD10 tumor samples | PTLD tumor sample | 4 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | ViraEpi4069 | Epstein barr virus (EBV) | Zp | NA | 103750 | 103750 | Hypo | 25% | PTLD10 tumor samples | PTLD tumor sample | 4 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | ViraEpi4070 | Epstein barr virus (EBV) | Zp | NA | 103802 | 103802 | Hypo | 25% | PTLD10 tumor samples | PTLD tumor sample | 4 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | ViraEpi4071 | Epstein barr virus (EBV) | Zp | NA | 103813 | 103813 | Hyper | 100% | PTLD10 tumor samples | PTLD tumor sample | 4 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | ViraEpi4072 | Epstein barr virus (EBV) | Zp | NA | 103821 | 103821 | Hypo | 25% | PTLD10 tumor samples | PTLD tumor sample | 4 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | ViraEpi4073 | Epstein barr virus (EBV) | Zp | NA | 103138 | 103138 | Intermediate | 60% | PTLD19 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | ViraEpi4074 | Epstein barr virus (EBV) | Zp | NA | 103181 | 103181 | Hyper | 100% | PTLD19 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | ViraEpi4075 | Epstein barr virus (EBV) | Zp | NA | 103272 | 103272 | Hyper | 100% | PTLD19 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | ViraEpi4076 | Epstein barr virus (EBV) | Zp | NA | 103467 | 103467 | CpG site absent | 0% | PTLD19 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | ViraEpi4077 | Epstein barr virus (EBV) | Zp | NA | 103530 | 103530 | Hyper | 100% | PTLD19 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | ViraEpi4078 | Epstein barr virus (EBV) | Zp | NA | 103544 | 103544 | Hyper | 100% | PTLD19 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | ViraEpi4079 | Epstein barr virus (EBV) | Zp | NA | 103552 | 103552 | Hypo | 40% | PTLD19 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | ViraEpi4080 | Epstein barr virus (EBV) | Zp | NA | 103638 | 103638 | No methylation | 0% | PTLD19 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | ViraEpi4081 | Epstein barr virus (EBV) | Zp | NA | 103686 | 103686 | Hyper | 100% | PTLD19 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | ViraEpi4082 | Epstein barr virus (EBV) | Zp | NA | 103798 | 103798 | Hypo | 40% | PTLD19 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | ViraEpi4083 | Epstein barr virus (EBV) | Zp | NA | 103705 | 103705 | Hyper | 80% | PTLD19 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | ViraEpi4084 | Epstein barr virus (EBV) | Zp | NA | 103726 | 103726 | Hypo | 0% | PTLD19 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | ViraEpi4085 | Epstein barr virus (EBV) | Zp | NA | 103735 | 103735 | Hypo | 0% | PTLD19 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | ViraEpi4086 | Epstein barr virus (EBV) | Zp | NA | 103746 | 103746 | Hypo | 0% | PTLD19 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | ViraEpi4087 | Epstein barr virus (EBV) | Zp | NA | 103750 | 103750 | Hypo | 0% | PTLD19 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | ViraEpi4088 | Epstein barr virus (EBV) | Zp | NA | 103802 | 103802 | Hyper | 80% | PTLD19 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | ViraEpi4089 | Epstein barr virus (EBV) | Zp | NA | 103813 | 103813 | Hyper | 100% | PTLD19 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | ViraEpi4090 | Epstein barr virus (EBV) | Zp | NA | 103821 | 103821 | Hyper | 100% | PTLD19 tumor samples | PTLD tumor sample | 5 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 | ViraEpi4091 | Epstein barr virus (EBV) | Zp | NA | 103138 | 103138 | Hyper | 100% | PTLD20 tumor samples | PTLD tumor sample | 4 PCR samples | Post-transplant lymphoproliferative disease (PTLD) | Methylation Specific PCR (MSP) | 22458933 |